%0 Journal Article
%T CE¨CMS-based urinary biomarkers to distinguish non-significant from significant prostate cancer
%J -
%D 2019
%R https://doi.org/10.1038/s41416-019-0472-z
%X Prostate cancer progresses slowly when present in low risk forms but can be lethal when it progresses to metastatic disease. A non-invasive test that can detect significant prostate cancer is needed to guide patient management
%U https://www.nature.com/articles/s41416-019-0472-z